Your search for bevacizumab returned 137 results

Your search for bevacizumab returned 137 results

Sort Results:

Relevant Recent
News

Keytruda Approved as First-Line Treatment of MSI-H or dMMR Colorectal Cancer

The FDA has approved Keytruda (pembrolizumab; Merck), a programmed death receptor-1 -blocking antibody, as monotherapy for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer.